| Period Ending | 31-Mar-2013 | 31-Dec-2012 | 30-Sep-2012 | 30-Jun-2012 |
|---|
|
Total Revenue
|
374,680
|
440,135
|
358,693
|
293,769
| | Cost of Revenue | 292,336 | 341,691 | 281,961 | 231,130 | | |
Gross Profit
|
82,344
|
98,444
|
76,732
|
62,639
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 57,084 | 63,769 | 54,392 | 52,739 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
25,260
|
34,675
|
22,340
|
9,900
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 705 | 777 | (8,674) | 519 |
|
Earnings Before Interest And Taxes | 25,965 | 35,452 | 13,666 | 10,419 |
|
Interest Expense | 3,762 | 5,133 | 3,236 | 4,180 |
|
Income Before Tax | 22,203 | 30,319 | 10,430 | 6,239 |
|
Income Tax Expense | 199 | 1,372 | 23 | 190 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 22,004 | 28,947 | 10,407 | 6,049 | |
|
Non-recurring Events |
|
Discontinued Operations | 113 | (374) | 238 | 223 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
22,117
|
28,573
|
10,645
|
6,272
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
22,117
|
28,573
|
10,645
|
6,272
|
|
1.40(2.85%) 8:56PM - Nasdaq Real Time Price